Market Access/ News/ News/ News/ R&D Basilea preps key US filing for MRSA antibiotic ceftobiprole Phil Taylor antibiotic, Basilea, ceftobiprole, infectious diseases, MRSA, Zevtera 0 Comment Basilea Pharmaceutica may finally be able to bring its antibiotic ceftobiprole to the US market – 13 years Share X Basilea preps key US filing for MRSA antibiotic ceftobiprole https://pharmaphorum.com/news/basilea-preps-key-us-filing-for-mrsa-antibiotic-ceftobiprole/
antibiotic, Basilea, ceftobiprole, infectious diseases, MRSA, Zevtera
0 Comment
